Peptides are suddenly everywhere, and one popular fitness creator just ranked the biggest names on a tier list.
Only one earned S tier.
Spoiler: it isn’t technically a peptide at all.
Several buzzy compounds landed far lower than social media hype would suggest.
Here is how each contender stacked up, and why.
Jump to:
- The Full Tier List at a Glance
- Semaglutide: A Tier, With Fine Print
- Tirzepatide: Double the Receptors, Bigger Effect
- Retatrutide: Three Receptors, One Big Catch
- BPC-157: The “Wolverine Peptide” Gets a Low C
- Epitalon and MOTS-c: Anti-Aging Promise, F Tier Proof
- NAD+: Popular, But Not a Peptide
- The S Tier Winner: Exercise
- Practical Takeaways
The Full Tier List at a Glance
- S tier: Exercise
- A tier: Semaglutide and tirzepatide (context matters)
- B tier: Retatrutide
- Low C tier: BPC-157
- D tier: NAD+
- F tier: Epitalon and MOTS-c
Curious why a gym staple beat every injectable? Keep reading.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
Semaglutide: A Tier, With Fine Print
Semaglutide, better known as Ozempic, is the heavyweight of the weight-loss category. Its mechanism is simple.
Semaglutide, aka Ozempic, works for fat loss by activating GLP-1 receptors, which makes you less hungry.
Comparing one year of diet and exercise alone against one year of diet and exercise plus semaglutide, the creator showed a clear edge for the drug group.
But the story doesn’t end there.
Muscle Loss and Side Effects Are Real
You will lose muscle if you don’t lift weights and eat enough protein, and nausea and diarrhea are quite common.
Appetite suppression means less food overall, and protein can slip through the cracks. Lifting weights becomes a non-negotiable.
Who Should (and Shouldn’t) Use It
I also don’t think it should be used by people who are already lean trying to get shredded, but it is safe for overweight people when prescribed by a medical doctor.
Verdict: A tier, but only for the right person under medical supervision.
Tirzepatide: Double the Receptors, Bigger Effect
Same idea except it activates two receptors, which makes you even less hungry and causes even more weight loss.
Same caveats apply. Same A tier placement, with context front and center.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
Retatrutide: Three Receptors, One Big Catch
Retatrutide targets three receptors, which the creator says drives even more weight loss.
It isn’t FDA approved as of right now, so I’m going to put it in B tier.
Translation: promising power, but no regulatory green light yet. Any product sold outside approved channels deserves extra suspicion.
BPC-157: The “Wolverine Peptide” Gets a Low C
BPC-157 carries a flashy nickname and an even flashier claim: faster injury healing.
Early data does look intriguing. Rats with leg injuries showed 50% more blood vessel formation.
Why the Hype Outruns the Science
That was in rats. And it’s only actually ever been studied in 30 humans, ever.
Rodent results often fail to carry over to people, and 30 participants is a tiny sample.
The anecdotes are strong, but most injuries heal on their own anyway, so it’s hard to know if it’s the BPC that’s working.
That is the classic trap. Natural recovery can easily masquerade as a miracle.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
Quality control adds another wrinkle. The creator’s bottom line: wait for more high-quality science before getting excited, hence a low C tier.
Epitalon and MOTS-c: Anti-Aging Promise, F Tier Proof
Both compounds have a plausible mechanism for longevity. Plausible, however, is not proven.
They’ve only actually been shown to extend lifespan in flies, mice, and rats. No reliable human evidence, so I’ve got to put them in F tier.
Extending a mouse’s life is a long way from extending yours.
NAD+: Popular, But Not a Peptide
NAD+ is the most popular longevity pick in this crowd. There’s a twist, though.
It’s not actually a peptide, it’s a coenzyme. The human evidence is quite weak anyway. I’m feeling D tier.
Big marketing, thin human data.
The S Tier Winner: Exercise
The final entry isn’t a peptide either. Yet it outperforms everything above.
If you want something simple that actually works, this is one of the most effective tools I’ve used to build strength, conditioning, and endurance without needing a full gym setup.
- Full-body training with one weight using swings, squats, and presses
- Solid cast iron build that feels stable and lasts for years
- Comfortable grip that makes high-rep workouts easier to handle
It can help you look fitter, healthier, it can heal your injuries, and help you live longer. Exercise. I’m putting it in S tier.
No prescription. No supply-chain worries. Zero mystery vials.
Practical Takeaways
- Start with movement: Build a routine before chasing any injectable.
- Lift weights: Resistance training protects muscle, especially during rapid weight loss.
- Prioritize protein: Appetite-suppressing medications make it easy to undereat.
- See a doctor first: GLP-1 drugs belong under medical supervision, not in a self-experiment.
- Stay skeptical: Rodent studies and glowing anecdotes aren’t human proof.
Peptides may keep dominating headlines. Training still wins the tier list.










